|
All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance
|
05/18/2013
|
|
Sterile Products Compounded, Repackaged, and Distributed by ApothéCure: Recall - Sterility Assurance Concerns
|
04/16/2013
|
|
All Sterile Compounded Products by Nora Apothecary And Alternative Therapies: Recall - Lack of Sterility Assurance
|
04/23/2013
|
|
Lyophilized Products Compounded by NuVision Pharmacy: Recall - Sterility Assurance Concerns
|
04/16/2013
|
|
Avastin Unit Dose Syringes by Clinical Specialties: Recall - Potential For Serious Eye Infection
|
03/20/2013
|
|
Azithromycin (Zithromax or Zmax): Drug Safety Communication - Risk of Potentially Fatal Heart Rhythms
|
03/12/2013
|
|
Balanced Solutions All Sterile Compounded Products: Recall - Lack of Sterility Assurance
|
04/22/2013
|
|
Clinical Specialties Compounding Pharmacy Products: Recall - All Sterile Products Recalled Due To Lack of Sterility Assurance
|
03/21/2013
|
|
Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
|
05/17/2013
|
|
The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products
|
05/08/2013
|
|
Ferrous Sulfate Tablets, 325 mg Labeled as Rugby Natural Iron Supplement: Recall - Bottle May Contain Meclizine HCl 25 mg Tablets
|
01/18/2013
|
|
Green Valley Drugs: Recall of All Lots of All Sterile Products - Quality Control Concerns
|
04/11/2013
|
|
Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas
|
03/14/2013
|
|
Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion
|
05/06/2013
|
|
Lactated Ringers and 5 Percent Dextrose Injection, USP, 1000 ML, Flexible Containers: Recall - Due to Non-Sterility
|
01/28/2013
|
|
Magnesium Sulfate: Drug Safety Communication - Recommendation Against Prolonged Use in Pre-term Labor
|
05/30/2013
|
|
Magnesium Sulfate Injection by Fresenius Kabi USA: Recall - Glass Particles in Vials
|
05/29/2013
|
|
Main Street Family Pharmacy in Tennessee: FDA Alerts Health Care Providers of Adverse Reactions Associated with Steroid Injections
|
06/13/2013
|
|
Med Prep Consulting Inc. Compounded Products: Recall - Potential Mold Contamination
|
03/18/2013
|
|
Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
|
05/21/2013
|
|
Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance
|
05/30/2013
|
|
Omontys (peginesatide) Injection by Affymax and Takeda: Recall of All Lots - Serious Hypersensitivity Reactions
|
02/23/2013
|
|
Pallimed Solutions, Inc. Sterile Compound Products: Recall - Visible Particulates Observed
|
03/27/2013
|
|
Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution
|
04/30/2013
|
|
Potiga (Ezogabine): Drug Safety Communication - Linked To Retinal Abnormalities And Blue Skin Discoloration
|
04/26/2013
|
|
Samsca (Tolvaptan): Drug Safety Communication - FDA Limits Duration and Usage Due To Possible Liver Injury Leading to Organ Transplant or Death
|
04/30/2013
|
|
Samsca (tolvaptan): Drug Warning - Potential Risk of Liver Injury
|
01/25/2013
|
|
Sensipar (Cinacalcet Hydrochloride): Drug Safety Communication - FDA Suspends Pediatric Clinical Trials After Report Of Death
|
02/26/2013
|
|
Sodium Chloride Injection 0.9 percent USP, 100 mL Flexible Containers by Hospira: Recall - Particulate Matter
|
04/26/2013
|
|
Sodium Chloride Injection, 0.9 percent, 1000 mL, Flexible Container: Recall - Brass Particulates
|
04/01/2013
|
|
Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches
|
05/06/2013
|
|
Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected
|
06/10/2013
|
|
Vistide (Cidofovir Injection) by Gilead: Recall - Presence Of Particulate Matter
|
02/16/2013
|
|
Warfarin 2 mg Tablets by Zydus Pharmaceuticals USA Inc.: Recall - Due to Oversized Tablets
|
06/12/2013
|
|
Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses
|
05/14/2013
|
|
Zyprexa Relprevv (Olanzapine Pamoate): Drug Safety Communication - FDA Investigating Two Deaths Following Injection
|
06/18/2013
|